| Literature DB >> 32461993 |
Harshima Wijesinghe1, Nayana Gunathilaka2, Saveen Semege3, Nishantha Pathirana4, Nuwani Manamperi2, Chandu de Silva1, Deepika Fernando5.
Abstract
Cutaneous leishmaniasis (CL) is a neglected tropical disease that is gaining importance in Sri Lanka and internationally. The clinical presentation, pathology, and method of parasite elimination in CL vary according to the species. Leishmania donovani is the causative organism for leishmaniasis in Sri Lanka. This collaborative cross-sectional study describes the clinicopathological features of cutaneous leishmaniasis among personnel of the tri-forces serving in the North and East of the country. The histology of fifty cases of CL confirmed by at least two methods (slit skin smear, lesion aspirate, tissue impression, and histology) was reviewed. The parasitic load was assessed semiquantitatively. The histological features were correlated with the clinical presentation and organism load. The majority (89.8%; n = 44) presented with a single lesion mostly located in the upper limb (69.4%). The lesion types included papule (34.7%), nodule (32.7%), and an ulcer (30.6%). The evolution time of lesions averaged 31.55 weeks. Epidermal changes were observed in 49 of the biopsies and included hyperkeratosis (90.0%; n = 45), acanthosis (44.0%; n = 22), atrophy (34.0%; n = 17), and interface change (66%; n = 33). Dermal changes were seen in all cases and were characterized by a lymphohistioplasmacytic inflammatory infiltrate of variable intensity with ill-formed granuloma in 19 cases (38%) and well-formed epithelioid granulomas in 22 cases (44%). Focal necrosis was present in 20% (n = 10). Leishmania amastigote forms were observed in 88% (n = 44). Transepidermal elimination (P = 0.025), granuloma (P = 0.027) formation, and type of lesion (P = 0.034) were significantly associated with the organism load. Granuloma formation was associated with a reduction in organism load, indicating that the macrophage activation played an important role in the control of the organism.Entities:
Mesh:
Year: 2020 PMID: 32461993 PMCID: PMC7222607 DOI: 10.1155/2020/4926819
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Epidermal changes of lesions among patients with cutaneous leishmaniasis.
| Epidermal change | Present | Absent |
|---|---|---|
| Ulceration | 7 (14%) | 43 (36%) |
| Transepidermal elimination of amastigotes | 7 (14%) | 43 (36%) |
| Hyperkeratosis | 45 (90%) | 5 (10%) |
| Parakeratosis | 21(42%) | 29 (58%) |
| Acanthosis | 22(44%) | 28 (56%) |
| Atrophy | 17 (34%) | 33 (66%) |
| Spongiosis | 17 (34%) | 33 (66%) |
| Exocytosis | 17 (34%) | 33 (66%) |
| Interface change | 33 (66%) | 17 (34%) |
| Crusting | 6 (12%) | 44 (88%) |
| Intraepidermal neutrophils | 13 (26%) | 37 (74%) |
Figure 1The spectrum of histopathological changes seen in the dermis (haematoxylin and eosin stain ×400): (a) diffuse lymphohistioplasmacytic infiltrate, (b) ill-defined granuloma, (c) well-defined granuloma with (i) multinucleated giant cells, and (d) diffuse lymphohistioplasmacytic infiltrate showing (ii) Leishmania amastigotes within macrophages.
Dermal changes of lesions among patients with cutaneous leishmaniasis.
| Dermal change | Category | Number (%) | |
|---|---|---|---|
| Type of inflammatory cells | Lymphocytes | Absent | 0 (0) |
| Fewer in number to other cells | 3 (6) | ||
| Equal in number to other cells | 40 (80) | ||
| Dominates other cells | 40 (80) | ||
| Plasma cells | Absent | 5 (10) | |
| Fewer in number to other cells | 27 (54) | ||
| Equal in number to other cells | 18 (36) | ||
| Dominates other cells | 0 (0) | ||
| Macrophages | Absent | 0 (0) | |
| Fewer in number to other cells | 3 (6) | ||
| Equal in number to other cells | 25 (50) | ||
| Dominates other cells | 22 (44) | ||
| Neutrophils | Absent | 16 (32) | |
| Fewer in number to other cells | 32 (64) | ||
| Equal in number to other cells | 2 (4) | ||
| Dominates other cells | 0 (0) | ||
| Eosinophils | Absent | 43 (86) | |
| Fewer in number to other cells | 7 (14) | ||
| Equal in number to other cells | 0 (0) | ||
| Dominates other cells | 0 (0) | ||
| Multinucleated giant cells | Present | 13 (26) | |
| Absent | 37 (74) | ||
|
| |||
| Nature of inflammatory infiltrate | Macrophage predominant | 22 (44) | |
| Lymphocyte predominant | 7 (14) | ||
| Lymphoplasmacytic | 1 (2) | ||
| Lymphohistiocytic | 9 (18) | ||
| Lymphohistioplasmacytic | 11 (22) | ||
|
| |||
| Degree of inflammation | Mild | 5 (10) | |
| Moderate | 16 (32) | ||
| Extensive | 29 (58) | ||
|
| |||
| Necrosis | Absent | 40 (80) | |
| Focal | 10 (20) | ||
| Diffuse | 0 (0) | ||
|
| |||
| Neuritis | Absent | 45 (90) | |
| Present | 5 (10) | ||
|
| |||
| Granuloma | Absent | 9 (18) | |
| Ill-defined granuloma | 19 (38) | ||
| Well defined granuloma | 22 (44) | ||
|
| |||
| Pattern of inflammation | Diffuse infiltrate | 9 (18) | |
| Ill-defined histiocytic infiltrate | 19 (38) | ||
| Well defined granuloma | 22 (44) | ||
Categorization of cases according to Ridley's parasitic index.
| Score | Parasitic load | No of cases (%) |
|---|---|---|
| 6 | More than, 100,000 parasites per standard section | 1 (2) |
| 5 | 10,100–100,000 parasites per standard section | 0 (0) |
| 4 | 1001–10,000 parasites per standard section | 9 (18) |
| 3 | 101–1000 amastigotes per standard section | 10 (20) |
| 2 | 11–100 amastigotes per standard section | 17 (34) |
| 1 | 1–10 amastigotes per standard section | 7 (14) |
| 0 | No amastigotes | 6 (12) |
| Total | 50 (100) |
Categorization of cases according to modified Ridley index.
| Group | Morphology | Organisms | No of cases (%) |
|---|---|---|---|
| Group 1 | Parasitized macrophages with variable lymphocytes and plasma cells | + | 8 (16) |
| Group 2 | Parasitized macrophages with lymphocytes, plasma cells, and ill-formed histiocytic granuloma | + | 19 (38) |
| Group 3 | A mixture of macrophages (with or without parasites), lymphocytes, plasma cells, and epithelioid granuloma | +/- | 17 (34) |
| Group 4 | Epithelioid granulomatous response (with or without Langhans type multinucleated giant cells) with a few lymphocytes and plasma cells but no amastigotes | — | 5 (10) |
| Nonspecific chronic inflammation with no amastigotes | 1 (2) | ||
| Total | 50 (100) | ||